IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
about
Interleukin-35: Expanding Its Job ProfileInterleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinomaElevated serum IL-35 and increased expression of IL-35-p35 or -EBI3 in CD4(+)CD25(+) T cells in patients with active tuberculosis.IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression.Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility GenesInterleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy.Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate.Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio.IL-35 Pretreatment Alleviates Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Inhibiting NF-κB Activation.Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant toleranceInterleukin 35 induced Th2 and Tregs bias under normal conditions in mice
P2860
Q26829619-55E98D6C-1547-4AF9-902B-F7D175CA9A8EQ35902052-209AE781-B0CE-478C-B196-0019C007151FQ36412024-B12E561C-6671-419F-92A3-982890B2B5CAQ36841195-CCA08CFF-37DE-4F34-AA89-2FD8093CB09EQ37564530-B03CC246-A088-474A-B07F-08840A13D36EQ37734489-D95EED2B-2EA9-43B2-9F7C-878407C8675CQ38650594-25280CBC-44B7-4ACE-9171-38E867770520Q42381249-FB45F242-DF41-49FF-95D3-28B9FA68B421Q47104079-A25516BD-C156-4240-AAF0-6438C3B20848Q47157103-E68DA3AF-D14D-499A-8938-42384CA7D0B6Q50643927-4692D8F5-19DF-4870-8B1B-4D7812563B4FQ58695273-D11F9734-7FFA-4A1D-A6CB-0E9D11D789D7Q58706304-8FBBAFF3-8EBA-49FD-A4AD-FAD309E3267C
P2860
IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@ast
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@en
type
label
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@ast
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@en
prefLabel
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@ast
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@en
P2093
P2860
P356
P1433
P1476
IL-35 mitigates murine acute g ...... graft-versus-leukemia effects
@en
P2093
D A A Vignali
P2860
P2888
P304
P356
10.1038/LEU.2014.310
P50
P577
2014-11-03T00:00:00Z
P5875
P6179
1024504964